Balyasny Asset Management’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-61
| Closed | -$5K | – | 1991 |
|
|
2018
Q1 | $5K | Buy |
+61
| New | +$5K | ﹤0.01% | 1695 |
|
|
2016
Q1 | – | Sell |
-70
| Closed | -$172K | – | 1360 |
|
|
2015
Q4 | $172K | Buy |
70
+10
| +17% | +$24.6K | ﹤0.01% | 975 |
|
|
2015
Q3 | $66K | Buy |
60
+11
| +22% | +$12.1K | ﹤0.01% | 912 |
|
|
2015
Q2 | $49K | Buy |
+49
| New | +$49K | ﹤0.01% | 869 |
|